Skip to content
Qvanteq
  • Home
  • Technology
    • Key benefits
    • Mechanism of Action
    • Publications
  • Products & Services
    • Neurovascular
    • Peripheral
    • Coronary
    • Other Devices
    • Consulting
  • About us
    • Management
    • Board of Directors
    • Quality system
    • Investors
  • News & Media
    • 2020
    • 2019
    • Archive
  • Contact
Qvanteq

Category: 2014

2014

First patient enrolled in the QUEST I clinical study

Posted on 25. November 20147. February 2018

Qvanteq AG today announced that it has enrolled the first patient in the First in Man (FiM) clinical study QUEST I, this is following earlier regulatory approval from the Dutch and Swiss authorities. The aim of the QUEST I study is to assess feasibility and safety of the Qstent, a bioactive, coating-free coronary stent. The […]

2014

Qvanteq AG is a Top 100 Swiss Startup

Posted on 17. September 20147. February 2018

Qvanteq was amongst the “Top 100 Swiss Startups”  for the 4th time in a row.

2014

CTI Swiss medtech best poster award 2014

Posted on 2. September 20147. February 2018

Qvanteq won the CTI best poster award. Read more

2014

Publication: J Biomed Mater, 2015

Posted on 26. June 201429. June 2017
2014

Qvanteq in “Handelszeitung”: “Am Puls des Herzens”

Posted on 30. April 20147. February 2018

A portrait of Qvanteq AG was published in the the Swiss business journal “Handelszeitung” under the the title “Am Puls des Herzens”.   Full article (g).

Posts navigation

1 2 Next

Recent News

  • Stop the activation of the blood coagulation cascade by your medical device
  • Make any surface antithrombotic
  • Qvanteq is using MedtechVault
  • In-vitro thrombogenicity screening capacity
  • Qvanteq has moved to new offices

Qvanteq AG

Technoparkstr. 1, 8005 Zürich, Switzerland
+41 44 500 98 90
info@qvanteq.com

More

  • Meet us
  • Subscribe
  • Contact
  • Disclaimer
Copyright Qvanteq AG